Annual accounts receivable:
$4.11M+$1.30M(+46.23%)Summary
- As of today (August 25, 2025), AGIO annual accounts receivable is $4.11 million, with the most recent change of +$1.30 million (+46.23%) on December 31, 2024.
- AGIO annual accounts receivable is now -82.48% below its all-time high of $23.45 million, reached on December 31, 2020.
Performance
AGIO Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$4.99M+$1.64M(+49.10%)Summary
- As of today (August 25, 2025), AGIO quarterly accounts receivable is $4.99 million, with the most recent change of +$1.64 million (+49.10%) on June 30, 2025.
- Over the past year, AGIO quarterly accounts receivable has increased by +$1.22 million (+32.54%).
- AGIO quarterly accounts receivable is now -78.74% below its all-time high of $23.45 million, reached on December 31, 2020.
Performance
AGIO Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AGIO Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.2% | +32.5% |
| 3 y3 years | - | +212.0% |
| 5 y5 years | -73.2% | -69.2% |
AGIO Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +86.3% | at high | +324.0% |
| 5 y | 5-year | -82.5% | +86.3% | -78.7% | +823.3% |
| alltime | all time | -82.5% | +763.2% | -78.7% | >+9999.0% |
AGIO Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $4.99M(+49.1%) |
| Mar 2025 | - | $3.34M(-18.6%) |
| Dec 2024 | $4.11M(+46.2%) | $4.11M(+31.8%) |
| Sep 2024 | - | $3.12M(-17.1%) |
| Jun 2024 | - | $3.76M(+8.9%) |
| Mar 2024 | - | $3.45M(+22.9%) |
| Dec 2023 | $2.81M(+27.4%) | $2.81M(+138.9%) |
| Sep 2023 | - | $1.18M(-47.8%) |
| Jun 2023 | - | $2.25M(+26.6%) |
| Mar 2023 | - | $1.78M(-19.4%) |
| Dec 2022 | $2.21M(-90.6%) | $2.21M(+21.3%) |
| Sep 2022 | - | $1.82M(+13.8%) |
| Jun 2022 | - | $1.60M(+195.9%) |
| Mar 2022 | - | $540.00K(-97.7%) |
| Dec 2020 | $23.45M(+53.1%) | $23.45M(+10.0%) |
| Sep 2020 | - | $21.32M(+31.5%) |
| Jun 2020 | - | $16.21M(-17.8%) |
| Mar 2020 | - | $19.72M(+28.7%) |
| Dec 2019 | $15.32M | $15.32M(+32.7%) |
| Sep 2019 | - | $11.54M(-6.7%) |
| Jun 2019 | - | $12.37M(+39.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $8.87M(-9.2%) |
| Dec 2018 | $9.77M(+299.2%) | $9.77M(+23.9%) |
| Sep 2018 | - | $7.89M(-62.3%) |
| Jun 2018 | - | $20.90M(+324.0%) |
| Mar 2018 | - | $4.93M(+101.3%) |
| Dec 2017 | $2.45M(-49.9%) | $2.45M(-41.8%) |
| Sep 2017 | - | $4.20M(-13.2%) |
| Jun 2017 | - | $4.84M(-57.0%) |
| Mar 2017 | - | $11.27M(+130.6%) |
| Dec 2016 | $4.89M(-40.6%) | $4.89M(-40.3%) |
| Sep 2016 | - | $8.18M(+4.2%) |
| Jun 2016 | - | $7.85M(+15.2%) |
| Mar 2016 | - | $6.81M(-17.2%) |
| Dec 2015 | $8.22M(+26.7%) | $8.22M(-9.4%) |
| Sep 2015 | - | $9.08M(-13.3%) |
| Jun 2015 | - | $10.47M(+49.3%) |
| Mar 2015 | - | $7.02M(+8.1%) |
| Dec 2014 | $6.49M(+1263.9%) | $6.49M(-65.4%) |
| Sep 2014 | - | $18.76M(>+9900.0%) |
| Jun 2014 | - | $0.00(-100.0%) |
| Mar 2014 | - | $2.62M(+450.2%) |
| Dec 2013 | $476.00K | $476.00K |
FAQ
- What is Agios Pharmaceuticals, Inc. annual accounts receivable?
- What is the all time high annual accounts receivable for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
- What is Agios Pharmaceuticals, Inc. quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Agios Pharmaceuticals, Inc.?
- What is Agios Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
What is Agios Pharmaceuticals, Inc. annual accounts receivable?
The current annual accounts receivable of AGIO is $4.11M
What is the all time high annual accounts receivable for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high annual accounts receivable is $23.45M
What is Agios Pharmaceuticals, Inc. annual accounts receivable year-on-year change?
Over the past year, AGIO annual accounts receivable has changed by +$1.30M (+46.23%)
What is Agios Pharmaceuticals, Inc. quarterly accounts receivable?
The current quarterly accounts receivable of AGIO is $4.99M
What is the all time high quarterly accounts receivable for Agios Pharmaceuticals, Inc.?
Agios Pharmaceuticals, Inc. all-time high quarterly accounts receivable is $23.45M
What is Agios Pharmaceuticals, Inc. quarterly accounts receivable year-on-year change?
Over the past year, AGIO quarterly accounts receivable has changed by +$1.22M (+32.54%)